Login
Breaking News
BlackRock   Netflix   GE Aerospace   TSMC   Bank of America    Morgan Stanley   Goldman Sachs Group   JPMorgan Chase   Citigroup  

Medtronic plc

Biotechnology:-Electromedical-&-Electrotherapeutic-Apparatus

MDT


20 On Hatch
Dublin , 2
Website
Investor Relation

News

  • Medtronic Plc. traded flat at $84.41 after the medical device provider reported higher revenue and earnings in the fourth quarter of 2025.

    Net sales climbed to $8.93 billion from $8.59 billion, net income edged up to $1.06 billion from $654 million, and diluted earnings per share rose to 82 cents from 49 cents a year ago.

    The medical technology company plans to separate its diabetes business into a standalone public company within 18 months.

    The company announced a cash dividend of 71 cents per share, or an annual amount of $2.84 per share, payable on July More

    May 22, 2025

  • Medtronic Plc. gained 0.3% to $86.30 after the American-Irish medical device company reported results for the fiscal 2025 third quarter.

    Revenue increased 2.5% to $8.29 billion from $8.09 billion, net income dropped to $1.29 billion from $1.32 billion, and diluted earnings per share rose to $1.01 from 99 cents a year ago.

    Sales in the cardiovascular, medical surgical, and diabetes segments marked a steady growth in the quarter, while the neuroscience segment dropped 3.7% to $769 million from $799 million in the same period last year.

    For the full year, Med More

    Feb 19, 2025

Executive/
Director

Executive/Director

Links

10K
10Q
Prospectus

Price

  • Last Close
  • $ 80.97
    $ +0.76 0.94 %
    Jan 3, 2025
  • 52-Week High/Low
  • $89.35 - $69.43
  • YTD
  • 1.3%

  • Trading Volume
  • 162,626
  • Market Cap Full
  • $ 107.7B
  • Shares Outstanding
  • 1329.7M
    Nov 24, 2023

Returns +
Q

2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 -2% 13.7% -0.1% 0.1% -5% 2.2% 6.6% 3.6% 5.7% 1.3%
Q2 15.7% 10.2% 10.5% 7.1% 4% 5.1% -19.1% 9.4% -8.8% -
Q3 0.6% -11.4% 15% 10.8% 8% 1.6% -10% -11.1% 9.8% -
Q4 -17.1% 4.1% -8.1% 3.7% 10.6% -17.5% -3.7% 6% -8.9% -

Returns +
M
J F M A M J J A S O N D
2025 1.3% - - - - - - - - - - -
2024 6.2% -4.8% 4.5% -8.8% 2.4% -2.5% 1.2% 9.8% - - - -7.5%

Returns +
A
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    9%-5%16%15%24%3%-10%-25%6%-3%1%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 1.06 1.12 -1.03 0.94 1.42 0.94 1.1 0.92
Q2 1.27 1.33 1.08 0.86 0.47 1 1.1 0.88
Q3 1.03 1.12 0.79 0.64 0.36 0.56 0.7 0.59
Q4 1.12 1.07 0.82 1.01 0.36 0.97 0.32 0.68
A 4.5 4.6 3.4 3.5 2.7 3.7 2.8 3.07

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

Dividend +

Dividend +

2020 2021 2022 2023 2024 2025
Q1 0.54 0.58 0.63 0.68 0.69 0.70
Q2 0.54 0.58 0.63 0.68 0.69 -
Q3 0.58 0.63 0.68 0.69 0.70 -
Q4 0.58 0.63 0.68 0.69 0.70 -
A 2.24 2.42 2.62 2.74 2.78 0.7

Outstanding Shares
(In Millions) +

Jan 16, 2024
2017 2018 2019 2020 2021 2022
Mar - 1355.4 1341.2 1340.2 1348.1 1341.5
Jun - 1351.7 1341.2 1341.3 1343.9 1328.7
Sep 1354.6 1350.5 1341.7 1344.2 1345.8 1329.2
Dec 1353.5 1343 1340.4 1346 1344.6 1330.2

Financial Statements
+

Annual
Download

SEC Filings

Date Form Type SEC Filings
Dec 9, 2024 4 Financial Statements
Oct 31, 2024 144 Financial Statements
Oct 29, 2024 144 Financial Statements
Oct 24, 2024 144 Financial Statements
Oct 24, 2024 11-K Financial Statements
Oct 23, 2024 144 Financial Statements
Oct 21, 2024 8-K Financial Statements
Oct 18, 2024 144 Financial Statements
Oct 17, 2024 144 Financial Statements
Sep 5, 2024 ARS Financial Statements

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 2.2 2.4 2.2 2.4 2.5
Fixed Asset Turnover 3.8 3.9 4.2 5.4 0.4
Total Asset Turnover 0.4 0.3 0.3 0.3 0.3
Leverage
Debt Ratio 0.9 1.2 1 1.1 1
Debt – Equity Ratio 0.4 0.5 0.4 0.5 0.5
Interest Coverage 8.1 5.1 2395.5 3.8 1.9
Equity multiplier 0.2 0.2 0.1 0.1 1.4
Data Sources Disclaimer